Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07231588 · ClinicalTrials.gov registry record · Early Phase 1
Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
A Early Phase 1 study of Radiation Injuries, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07231588 is a Early Phase 1 study of Radiation Injuries that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07231588, a Early Phase 1 study of Radiation Injuries, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The researchers will study if the probiotics lessen gastrointestinal toxicity during pelvic radiation.
Conditions Studied
Interventions
- BIOLOGICAL Pendulum Glucose Control (PGC)
Study Locations (1)
Ohio
- University of Cincinnati Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-01-29 |
| Est. Completion | 2026-12-29 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07231588
The ClinicalTrials.gov registry entry for NCT07231588 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Injuries appearing as the primary indexed condition, and to 1 intervention - of which Pendulum Glucose Control (PGC) is the first listed.
NCT07231588 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07231588 about?
NCT07231588 is a clinical study titled "Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation". This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The researchers will study if the probiotics lessen gastrointestinal toxicity during pelvic radiation.
What is the current status of trial NCT07231588?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2026-01-29. Estimated completion is 2026-12-29.
What conditions does trial NCT07231588 study?
This clinical trial studies the following conditions: Radiation Injuries.
What interventions are being tested in trial NCT07231588?
The interventions under investigation include: Pendulum Glucose Control (PGC) (BIOLOGICAL).
Who is sponsoring clinical trial NCT07231588?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07231588 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.